Page last updated: 2024-11-06

lysergic acid diethylamide and Leukemia, Myeloid, Acute

lysergic acid diethylamide has been researched along with Leukemia, Myeloid, Acute in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goh, K1
Bauman, AW1
Grossbard, L1
Rosen, D1
McGilvray, E1
De Capoa, A1
Miller, O1
Bank, A1

Other Studies

2 other studies available for lysergic acid diethylamide and Leukemia, Myeloid, Acute

ArticleYear
Lysergic acid diethylamide and acute leukemia.
    Journal of the American Medical Women's Association (1972), 1978, Volume: 33, Issue:10

    Topics: Adult; Humans; Leukemia, Myeloid, Acute; Lysergic Acid Diethylamide; Male

1978
Acute leukemia with Ph1-like chromosome in an LSD user.
    JAMA, 1968, Sep-09, Volume: 205, Issue:11

    Topics: Adult; Bone Marrow; Chromosome Aberrations; Chromosome Disorders; Hallucinogens; Humans; Karyotyping

1968